Adaptive Endoluminal Support Systems for Personalized Cardiovascular Care

Publication ID: 24-11857414_0010_PTD
Published: October 28, 2025
Category:Future Evolutions & Paradigm Shifts

Legal Citation

pr1or.art Inc., “Adaptive Endoluminal Support Systems for Personalized Cardiovascular Care,” Published Technical Disclosure No. 24-11857414_0010_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857414_0010_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,414.

Summary of the Inventive Concept

This inventive concept envisions a next-generation endoluminal support structure that can dynamically adapt to a patient's unique physiology and anatomy in real-time, providing unprecedented personalized care for cardiovascular diseases.

Background and Problem Solved

The original patent described a repositionable endoluminal support structure, but it had limitations in terms of customization and real-time adaptability. The new inventive concept addresses these limitations by integrating sensors, AI algorithms, and micro-actuators to create a truly adaptive system that can respond to changing patient conditions.

Detailed Description of the Inventive Concept

The new inventive concept comprises a sensor array that continuously monitors physiological conditions within a patient's vessel, and a micro-actuator system that dynamically adjusts the support structure's geometry in response to real-time sensor data. The system can be integrated with artificial intelligence algorithms to generate customized support structure designs based on patient-specific data. The prosthetic valve can also be equipped with integrated sensors and AI-powered decision support, enabling autonomous adjustments to its shape and function. Furthermore, the system can be deployed using a minimally invasive procedure with a robotic catheter system featuring real-time imaging and navigation capabilities. The modular endoluminal support platform allows for interchangeable modules with distinct geometries and material properties, ensuring a high degree of customization and adaptability.

Novelty and Inventive Step

The new inventive concept introduces a paradigm shift in endoluminal support structures by incorporating real-time sensing, AI-driven customization, and micro-actuation. These features enable a level of adaptability and personalization that was not possible with the original patent, making the new inventive concept novel and non-obvious.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include the use of different sensor modalities, such as optical or acoustic sensors, or the integration of additional AI algorithms for predictive analytics. Variations of the modular platform could include different module geometries, materials, or surface coatings to accommodate specific patient needs or vessel anatomies.

Potential Commercial Applications and Market

The adaptive endoluminal support system has significant commercial potential in the cardiovascular device market, with potential applications in treating a range of cardiovascular diseases, including atherosclerosis, aneurysms, and heart valve disorders. The system's ability to provide personalized care could lead to improved patient outcomes, reduced healthcare costs, and increased market share for companies that adopt this technology.

CPC Classifications

SectionClassGroup
A A61 A61F2/2427
A A61 A61F2/24
A A61 A61F2/243
A A61 A61F2/2409
A A61 A61F2/2412
A A61 A61F2/2418
A A61 A61F2/2469
A A61 A61F2/844
A A61 A61F2/2421
A A61 A61F2/82
A A61 A61F2/94
A A61 A61F2210/0076
A A61 A61F2220/0041
A A61 A61F2220/0075
A A61 A61F2230/0054
A A61 A61F2230/0091
A A61 A61F2250/001
A A61 A61F2250/0004
Y Y10 Y10T29/49826

Original Patent Information

Patent NumberUS 11,857,414
TitleRepositionable endoluminal support structure and its applications
Assignee(s)Edwards Lifesciences CardiAQ LLC